Jon Salkin joins LifeScan as Chief Executive Officer with more than two decades of experience leading healthcare, life sciences and medical technology companies through transformation and growth. Most recently, he served as CEO of Antylia Scientific, where he led the repositioning of Cole-Pamer, a Thermo Fisher carve-out and legacy laboratory distribution business, into a global life sciences and bioprocessing platform through a sustained program of operational improvement and strategic M&A. Earlier in his career, Jon served as Executive Vice President of Devicor Medical Products, leading the carve-out of Johnson & Johnson’s Breast Care business through its acquisition by Danaher. He holds a BA, MBA and JD from Case Western Reserve University.